ClinicalTrials.gg
RecruitingNCT00411060Updated Sep 3, 2026

Clinical Orthopaedic Data Bank (Acute and Chronic)

An observational study in Osteoarthritis, Osteosarcoma and Scoliosis, sponsored by University of Florida. Recruiting at 1 site in United States. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by University of Florida · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
10,000
Sex
All
01

Study summary

Data involving orthopaedic conditions and rehabilitation aspects of musculoskeletal and neuromuscular disorders will be collected and stored as part of the normal clinical care of patients seen in the University of Florida (UF) and Shands Orthopaedics and Sports Medicine Institute.

Read the detailed description

All patients seen the Orthopaedic clinic will be informed of the data collection and asked to participate. If the patient is agreeable to participation, informed consent will then be obtained.

02

Conditions studied

  • Osteoarthritis
  • Osteosarcoma
  • Scoliosis
  • Cerebral Palsy

Keywords

  • Rotator Cuff Tear
03

In context

Osteoarthritis

2,974 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.

This study's planned enrollment of 10,000 is above the median of 100 across 601 observational studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

University of Florida is the lead sponsor of 1,287 studies on the registry; 199 are open to participants now.

Of its 180 completed or terminated interventional studies of FDA-regulated products, 143 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Orthopaedic clinic

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients seen in the UF\&Shands Orthopaedics and Sports Medicine Institute will be asked to sign an .

Exclusion criteria

Exclusion Criteria:

  • No exclusions, all patients interested in participation will be asked to sign an .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
10,000 participants (estimated)
06

What researchers measure

Primary outcomes

  1. Retrospective data

    Medical Record information will be used as needed for a future IRB retrospective study

    Time frame: 2007 to present, until 2020

07

Study locations

1 of 1 sites recruiting
08

References and documents

09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2007, a primary completion of Aug 2027 and a completion of Aug 2027. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 12, 2006
First posted
Dec 13, 2006
Start
Jan 2007
Primary completionEst.
Aug 14, 2027
CompletionEst.
Aug 14, 2027
Last update
Sep 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00411060
Responsible party
Sponsor
First posted
Dec 13, 2006
Start date
Jan 2007
Primary completion
Aug 14, 2027 (estimated)
Completion
Aug 14, 2027 (estimated)
Last update
Sep 3, 2026

Study contacts

MaryBeth Horodyski, EdD
Contact
horodmb@ortho.ufl.edu
352-273-7379
Parker Gibbs, MD
principal investigator · UF Department of Orthopaedics and Rehabilitation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion